"Krankenhaus mit Spezialisierung auf Gelenkschmerzen, Krebserkrankungen und Herzerkrankungen"

During the past decade, St. Marien - Krankenhaus Siegen GMBH conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Marien - Krankenhaus Siegen GMBH" #1 sponsor was "German CLL Study Group" with 7 trials, followed by "CVRx, Inc." with 3 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored, "Dominik Paul Modest" with 1 trials sponsored and "Heidelberg University" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Marien - Krankenhaus Siegen GMBH" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "CRO De. med Kottmann GmbH & Co" with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator and "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "St. Marien - Krankenhaus Siegen GMBH" are "Chronic Lymphocytic Leukemia" (5 trials), "Leukemia" (4 trials), "Lymphoma" (3 trials), "Heart Failure" (2 trials) and "Anemia" (1 trials). Many other conditions were trialed in "St. Marien - Krankenhaus Siegen GMBH" in a lesser frequency.

Most popular intervention types in "St. Marien - Krankenhaus Siegen GMBH" are "Drug" (16 trials), "Biological" (10 trials), "Device" (5 trials), "Procedure" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "Fludarabine" (3 trials), "Rituximab" (3 trials), "doxorubicin hydrochloride" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. Marien - Krankenhaus Siegen GMBH" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "St. Marien - Krankenhaus Siegen GMBH". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in St. Marien - Krankenhaus Siegen GMBH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Marien - Krankenhaus Siegen GMBH, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".